Published 02/01/2012 - 12:44 p.m. CDT
Working-age adults who use two or more
prescription medications may be at
risk for
becoming seriously injured after falling in the
home,
researchers found.
In a study of
young and middle-age adults,
using at least two
medications was associated with an increased
likelihood of dying from or being hospitalized for
a falling injury ….
Antihypertensives and
cholesterol-lowering drugs were the most common
medications involved.
"The risk
of falls
may be increased as a result of both the
intentional and
unintentional effects of
pharmacological therapy such as orthostatic
hypotension, psychomotor impairment,
extra-pyramidal symptoms, and
dizziness."
Published 01/31/2012 - 11:50 a.m. CDT
Overuse of therapeutic
procedures, diagnostic tests,
and medications is
an
understudied problem that may
account for as much as 30% of
healthcare spending in the
United States and result in
harm to patients.
The 4
most common health services
examined in the studies
included in the
review were
antibiotics for upper
respiratory infections,
coronary
angiography,
carotid endarterectomy, and
coronary artery bypass
grafting
and
revascularization.
Published 01/31/2012 - 7:33 a.m. CDT
Ratings agency Standard
& Poor's warned it may
downgrade "a
number of
highly rated" Group of 20
countries from 2015 if their
governments fail to enact
reforms to curb rising
healthcare spending and
other costs related to ageing
populations.
"If
governments do not change
their social protection
systems, they will likely
become unsustainable."
"If no reforms are
adopted, healthcare-related
credit
downgrades would
likely start within three
years..."
"...
developed nations will
eventually become the victims
of their
social safety
nets."
"S&P said it
was not too late for G20
countries to
tackle the
problem, but reforms to
contain age-related spending
needed
be coupled with
efforts to balance budgets by
2016, which would be
enough
to offset rising healthcare
costs by 2050."
Published 01/25/2012 - 11:18 a.m. CDT
The Foundation for
Chiropractic Progress (F4CP),
architect of the
chiropractic profession's
longest running public
awareness campaign has
recognized Foot Levelers and
Standard Process as its
highest cumulative
corporate
contributors. Foot Levelers'
total contributions surpassed
$1.2 million and Standard
Process' contributions
exceeded one-half
million.
Published 01/25/2012 - 6:15 a.m. CDT
Just 1% of the U.S.
population accounted for 22%
of all healthcare spending in
2009.
Published 01/23/2012 - 5:48 a.m. CDT
In response to radiology
residents "systematically"
sharing answers on
their
certification exams, the
American Board of Radiology
(ABR) is
implementing a new
testing procedure that relies
less on memorization of
facts and more on testing
concrete skills.
A
CNN investigation revealed to
the public what appears to be
a
well-known fact in the
radiology community: Residents
preparing for
their board
certification exams often get
a leg up by studying past
questions, which come from a
repository contributed to by
past
test-takers.
Published 01/21/2012 - 6:34 a.m. CDT
48% of all people in the
US use drug therapy.
Physicians order 2.3
billion drugs annually.
74%
of physician office visits
involve drug
therapy.
Hospital
outpatient departments ordered
280.1 million drugs.
76% of
hospital outpatient department
visits involve drug
therapy.
Hospital
Emergency Departments ordered
238.3 million drugs.
78% of
hospital Emergency Department
visits involve drug
therapy.
Published 01/20/2012 - 6:06 a.m. CDT
One American in five
reported having trouble paying
medical bills in
2010,
according to a study by the
Center for Studying Health
System
Change.
Compared with 2003,
the percentage of families
with problems paying
medical
bills in 2010 was
significantly higher (15%
versus 21%). That
increase
reflects the rise in the cost
of healthcare, which grew
faster
than salaries and the
U.S. economy as a whole.
Published 01/19/2012 - 6:00 a.m. CDT
A new review of the
influenza drug oseltamivir
(Tamiflu) has raised
questions about both the
efficacy of the medication and
the commitment
of its maker
to supply enough data for
claims about the drug to be
evaluated by independent
experts. It also raises
questions about the
entire
process of systematic
review.